Scott B Capps Artivion, Inc. (AORT) insider trading activity

Scott B Capps is VP, Clinical Research of ARTIVION, INC.. Currently has a direct ownership of 153,203 shares of AORT, which is worth approximately $3.92 Million. The most recent transaction as insider was on Mar 12, 2021, when has been sold 1,393 shares (Common Stock) at a price of $25.05 per share, resulting in proceeds of $34,895. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 153K

0% 3M change

0% 12M change

Total Value Held $3.92 Million

Scott B Capps Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 12 2021	SELL Payment of exercise price or tax liability	$34,895 $25.05 p/Share	1,393 Reduced 0.9%	153,203 Common Stock
Mar 05 2021	SELL Payment of exercise price or tax liability	$5,010 $24.44 p/Share	205 Reduced 0.13%	154,596 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$14,306 $25.41 p/Share	563 Reduced 0.36%	154,801 Common Stock
Feb 23 2021	BUY Grant, award, or other acquisition	-	3,176 Added 2.0%	155,364 Common Stock
Feb 17 2021	BUY Grant, award, or other acquisition	-	3,548 Added 2.28%	152,188 Common Stock
Dec 15 2020	SELL Open market or private sale	$178,530 $21.34 p/Share	8,366 Reduced 5.33%	148,640 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$99,700 $9.97 p/Share	10,000 Added 5.99%	157,006 Common Stock

SBC

Scott B Capps

VP, Clinical Research

Kennesaw, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AORT shares.

Notify only if

Value

Insider Trading

Get notified when an Artivion, Inc. insider buys or sells AORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to ARTIVION, INC.

Track Activities on AORT

Account